Bruchard, Mélanie http://orcid.org/0000-0003-0004-2887
Geindreau, Mannon
Perrichet, Anaïs
Truntzer, Caroline
Ballot, Elise
Boidot, Romain http://orcid.org/0000-0001-9956-1737
Racoeur, Cindy
Barsac, Emilie
Chalmin, Fanny
Hibos, Christophe
Baranek, Thomas
Paget, Christophe
Ryffel, Bernhard http://orcid.org/0000-0003-2897-8230
Rébé, Cédric http://orcid.org/0000-0001-8831-145X
Paul, Catherine
Végran, Frédérique
Ghiringhelli, François http://orcid.org/0000-0002-5465-8305
Funding for this research was provided by:
Association pour la Recherche Thérapeutique Anti-Cancéreuse
fondation de francefondation ligue contre le cancer
Agence Nationale de la Recherche (ANR-11-LABX0021)
Labex LipSTIC
Article History
Received: 1 April 2021
Accepted: 13 December 2021
First Online: 31 January 2022
Competing interests
: F.G. received honoraria for oral communication from Lilly, Sanofi, BMS, Astra Zeneca and Amgen; received funding for clinical trials by Astra Zeneca; received a travel grant from Roche France, Amgen and Servier; and is an advisory board member for Merck Serano, Amgen, Roche France and Sanofi. All other authors have no competing interests.